Thus, tumor cells may express CD80/86 to suppress T cell activity via binding to CTLA4, or express PD-1 ligands PD-L1 (CD274) or PD-L2 (PDCD1LG2, PD-2 ligand). Here, PDCD1LG2 is linked to neoplasm.